Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-01-29

FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Prasco Laboratories)

View source ↗

Summary

FDA approves a generic form of dextroamphetamine sulfate from Prasco Laboratories under an Original Application, for ADHD and narcolepsy indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextroamphetamine Sulfate (generic) (Dextroamphetamine sulfate)

Snippet

ORIG AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)